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Pathophysiology of Ovarian Cancer
Christina M. Eagle BSN RN
Significance of Pathophysiology
Implications for 
Nursing Care
Otterbein University, Westerville, Ohio
Case Study
• A 20-year-old female presented to her gynecologist complaining of abdominal pain, pelvic pain, 
and pain in the small of her back, which had begun to worsen. She also felt bloated and was 
having frequent problems with indigestion and gas. In addition, she was tired all the time and 
rarely went to the gym anymore.
• Her medical history showed her to be a healthy and athletic female. She admitted to drinking 
occasionally at social events but denied having ever smoked. She had been receiving annual 
gynecological exams since she was 18 years old, and her menstrual history has been 
unremarkable. Her family history showed that her mother was a breast and ovarian cancer 
survivor. The patient was not on birth control medication, but she stated that she practices 
safe sex with the use of condoms.
• The gynecologist performed a pelvic examination of the patient’s vagina, uterus, rectum and 
pelvis, including ovaries, and checked for masses or growths. He followed the pelvic exam with 
a transvaginal ultrasound to better detect the presence of abnormal growths in the 
reproductive organs. The transvaginal ultrasound revealed a mass on her right ovary (PRIME 
Education, 1997-2019).
Introduction
• Worldwide,	approximately	240,000	women	are	diagnosed	with	ovarian	cancer	each	year,	and	140,200	were	projected	to	succumb	to	this	disease	in	2016.
• This	case-to-fatality	ratio	is	nearly	three	times	that	of	breast	cancer,	making	ovarian	cancer	the	most	lethal	gynecological	malignancy	in	developed	countries.
• Patients	with	stage	III	or	IV	disease	have	a	dismal	25%	5-year	survival	rate	(Kroeger,	Jr.	&	Drapkin,	2017).
Oncology	became	a	way	of	life	in	2002	with	the	diagnosis	of	this	author’s	4-year-old	
daughter	with	metastatic	Ewing’s	Sarcoma,	a	form	of	bone	or	soft	tissue	cancer.	During	
this	life	journey,	this	author	made	the	decision	to	pursue	an	education	in	nursing.	After	
the	passing	of	said	daughter	in	2003,	everything	oncology-related	became	this	nurse’s	
passion.	For	the	past	seven	years	this	nurse	has	practiced	in	radiation	oncology	with	the	
hope	and	desire	to	be	more	of	an	advocate	to	those	battling	a	cancer-related	diagnosis	as	
an	advanced	practice	nurse.
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Signs & SymptomsOvarian	cancer	is	difficult	to	detect,	especially	in	the	early	stages	(National	Ovarian	Cancer	Coalition).	This	is	partly	due	to	the	fact	that	the	ovaries	– two	small,	almond-shaped	organs	on	either	side	of	the	uterus	– are	deep	within	the	abdominal	cavity	(NOCC).	The	following	are	often	identified	by	women	as	some	of	the	signs	and	symptoms	of	ovarian	cancer:
• Bloating
• Pelvic	or	abdominal	pain
• Trouble	eating	or	feeling	full	quickly
• Feeling	the	need	to	urinate	urgently	or	often	(NOCC).Other	symptoms	of	ovarian	cancer	can	include:
• Fatigue
• Upset	stomach	or	heartburn
• Back	pain
• Pain	during	sex
• Constipation	or	menstrual	changes	(NOCC).When	the	symptoms	are	persistent,	when	they	do	not	resolve	with	normal	interventions	(like	diet	change,	exercise,	laxatives,	rest)	it	is	imperative	for	a	woman	to	see	her	doctor	(NOCC).	Persistence	of	symptoms	is	key	(NOCC).
Underlying Pathophysiology
• The	majority	of	ovarian	cancers	are	of	epithelial	origin,	whereas	fewer	ovarian	cancers	develop	from	the	remaining	cell	types,	such	as	sex-cord	stromal,	germ	cell,	or	mixed	cell-type	tumors.
• The	most	common	histological	subtypes	of	epithelial	ovarian	carcinomas	are	serous	(68-71%),	endometrioid	(9-11%),	clear	cell	(12-13%),	mucinous	(3%),	transitional	(1%),	and	mixed	histologies (6%).
• Several	groups	have	now	convincingly	established	that	there	are	2	distinct	types	of	epithelial	ovarian	carcinoma:	type	I	and	type	II.
• Type	I	tumors	arise	via	well-recognized	sequence	either	from	borderline	serous	tumors	or	from	endometriosis	and	include	low-grade	serous	carcinoma,	endometrioid,	and	clear-cell	carcinoma.
• These	tumors	are	often	early	stage	and	low-grade	tumors,	with	a	relatively	indolent	disease	course.
• Type	II	carcinomas	are	more	frequent,	usually	of	serous	histology,	are	high	grade,	and	seem	to	originate	from	the	fimbrial epithelium	in	up	to	60%	of	the	cases.
• Subsequently,	high-grade	serous	carcinomas	present	clinically	as	stage	3	or	4	disease,	consistent	with	the	hypothesis	of	peritoneal	seeding	by	malignant	cells	from	the	fimbriated	end	of	the	tubes.
• At	the	time	of	diagnosis,	the	majority	of	epithelial	ovarian	cancers	are	advanced-stage,	high-grade	serous	carcinomas	and	have	a	poor	prognosis	compared	with	early-stage	carcinomas	(Nezhar,	Apostal,	Nezhat &	Pajovic,	2015).
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Becoming	familiar	with	and		educating	women	about	risk	factors	and	the	elusive	symptoms	of	ovarian	cancer	can	increase	patient	autonomy	and	advocacy,	as	well	as	potentially	improve	patient	outcomes	for	those	affected	by	ovarian	cancer	(Stewart,	Ralyea &	Lockwood,	2019).
• There	is	no screening	test	for	ovarian	cancer	and	with	diagnosis	often	in	the	late	stages, recurrence	is	high	in	this	population.
• Early	identification	can	range	from	knowing	the	vague	symptoms	associated	with	the	cancer	to	prophylactic	surgical	removal	of	at-risk	tissue.
• Standard	treatment	for	ovarian	cancer	is	surgery	followed	by combination	chemotherapy.
• Although	advances	are	being	made,	ovarian	cancer	remains	the	most	fatal	female gynecologic	cancer	(Stewart,	Ralyea &	Lockwood,	2019).
Conclusion
• Clinical	observations	and	the	new	recent	evidence	for	the	pathogenesis	of	ovarian	cancer	have	set	ground	for	implementing	new	strategies	for	screening	and	prevention	programs	to	reduce	the	incidence	of	epithelial	ovarian	cancer	.
• Until	specific	markers	are	developed,	able	to	detect	different	histological	epithelial	cancers,	it	is	reasonable	to	monitor	women	for	risk	factors	and	pursue	risk-reducing	medical	and	surgical	treatment	options	to	reduce	the	risk	of	these	types	of	cancers	(Nezhar,	Apostal,	Nezhat &	Pajovic,	2015).
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